You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
On the way to specifically targeting minimal residual disease?
|
---|---|
Published in |
Breast Cancer Research, October 2008
|
DOI | 10.1186/bcr2148 |
Pubmed ID | |
Authors |
Gerhard Gebauer |
Abstract |
The target of all adjuvant systemic therapies after surgery in breast cancer is the eradication of a minimal subclinical residual disease. Although it is well known that tumor cell dissemination takes place already at an early stage of the disease, little is known about the tumorbiological parameters of these residual cells. Selection of patients eligible for adjuvant endocrine therapies is based on the analysis of receptor expression in the primary tumor - although the analysis is directed against disseminated tumor cells, these cells may vary in receptor expression in comparison with the primary tumor. |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 9 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 2 | 22% |
Student > Doctoral Student | 2 | 22% |
Other | 1 | 11% |
Student > Master | 1 | 11% |
Unknown | 3 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 3 | 33% |
Psychology | 2 | 22% |
Unknown | 4 | 44% |